AAX Biotech strengthens Board of Directors

New Board Member at biotech start-up AAX Biotech, Patrik Strömberg, brings more than two decades of extensive experience in the pharmaceutical industry and a solid background in research and development, innovation management and business development. He has extensive experience from key positions at pharmaceutical companies such as AstraZeneca and Biovitrum/Sobi. Strömberg has been CEO of AnaCardio since 2021. He holds a PhD in biochemistry from Karolinska Institutet and an MBA from Stockholm University. AAX Biotech was founded by experts from Karolinska Institutet in Stockholm, Sweden.